# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Jones Trading analyst Catherine Novack initiates coverage on Larimar Therapeutics (NASDAQ:LRMR) with a Buy rating and announ...
Baird analyst Joel Beatty initiates coverage on Larimar Therapeutics (NASDAQ:LRMR) with a Outperform rating and announces Pr...